RDInvesting Provides Investors with Free In-Depth Equity Reports on AUO, CREE, PAYX and RMD
Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.
AU Optronics Corp. (NYSE: AUO) shares declined 3.27 percent to close at $3.55 a share Wednesday. The stock traded between $3.48 and $3.58 on volume of 3.58 million shares traded. Analysts at Citigroup have recently downgraded the company’s rating to “sell” from “buy”. Shares of AU Optronics have fallen over 21.0 percent year-to-date.
Find out more about AU Optronics including full access to the free equity report at:
www.RDInvesting.com/AUO
Cree, Inc. (NASDAQ: CREE) shares gained 0.17 percent to close at $68.87 a share Wednesday. The stock traded between $68.27 and $69.44 on volume of 1.19 million shares traded. Analysts at Garp Research have recently downgraded the company’s rating to “neutral” from “buy”. Shares of Cree have gained over 102.0 percent year-to-date.
Find out more about Cree including full access to the free equity report at:
www.RDInvesting.com/CREE
Paychex, Inc. (NASDAQ: PAYX) shares increased 0.36 percent to close at $39.20 a share Wednesday. The stock traded between $39.06 and $39.34 on volume of 1.69 million shares traded. Analysts at Argus have recently initiated coverage on the company with a “hold” rating. Shares of Paychex have gained approximately 26.0 percent year-to-date.
Find out more about Paychex including full access to the free equity report at:
www.RDInvesting.com/PAYX
ResMed Inc. (NYSE: RMD) shares closed at $45.13 Wednesday. The stock traded between $44.66 and $45.59 on volume of 1.33 million shares traded. Analysts at Goldman have recently downgraded the company’s rating to “neutral” from “buy”. Shares of ResMed have gained approximately 8.5 percent year-to-date.
Find out more about ResMed including full access to the free equity report at:
www.RDInvesting.com/RMD
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.
Contact:
Research Driven Investing
info@rdinvesting.com